The 10-year risk for prostate cancer increased from 0.3% in the lowest-risk group (PSA ≤ 1 ng/mL and lower gene score) to 72.5% in the highest-risk group (PSA > 10 ng/mL and higher gene score). The gene discussed is KLK3; the disease is prostate carcinoma.